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PRENATAL DYSTHYMIA VERSUS MAJOR DEPRESSION
EFFECTS ON MATERNAL CORTISOL AND FETAL
GROWTH
Tiffany Field, Ph.D.,1,2 Miguel A. Diego, Ph.D.,1 Maria Hernandez-Reif, Ph.D.,1 Barbara Figueiredo, Ph.D.,3
Angela Ascencio,1 Saul Schanberg, M.D., Ph.D.,4 and Cynthia Kuhn, Ph.D.4
To determine differences between pregnant women diagnosed with Dysthymia
versus Major Depression, depressed pregnant women (N5 102) were divided by
their diagnosis into Dysthymic (N5 48) and Major Depression (N5 54) groups
and compared on self-report measures (depression, anxiety, anger, daily hassles
and behavioral inhibition), on stress hormone levels (cortisol and norepi-
nephrine), and on fetal measurements. The Major Depression group had more
self-reported symptoms. However, the Dysthymic group had higher prenatal
cortisol levels and lower fetal growth measurements (estimated weight, femur
length, abdominal circumference) as measured at their first ultrasound (M5 18
weeks gestation). Thus, depressed pregnant women with Dysthymia and Major
Depression appeared to have different prenatal symptoms. Depression and
Anxiety 25:E11–E16, 2008. Published 2008 Wiley-Liss, Inc.y
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INTRODUCTION
Many researchers studying the effects of maternal
depression on prenatal development have grouped
depression diagnoses, namely Major Depression Dis-
order and dysthymia mothers together. These dis-
orders may have very different effects on prenatal
development if the mothers are experiencing these
disorders differently during pregnancy. Thus, the
purpose of this study was to explore the differences
between pregnant women experiencing Major Depres-
sion Disorder (MDD) and Dysthymia on: (1) their self-
reported feelings including depressive symptoms,
anxiety and anger, their daily hassles and their style of
coping (behavioral approach or withdrawal); (2) their
neuroendocrine stress hormones (cortisol and norepi-
nephrine); and (3) the growth measures of the fetuses
from ultrasounds.
Major depression is usually considered more severe
than dysthymia. However, the literature is somewhat
mixed on that issue. For example, major depression has
been considered by some researchers to be more severe
and less chronic than Dysthymia [Klonsky and
Bartelson, 2000]. In the study by Klonsky and
Bartelson [2000], more physical/somatic symptoms
were noted for Major Depression than Dysthymia,
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leading to the authors’ suggestion that Major Depres-
sive Disorder is more severe than Dysthymia.
In another study addressing the psychosocial correlates
and treatment seeking of these two groups, the affec-
tive symptoms appeared to be similar for Major
Depression and Dysthymia [Flament et al., 2001].
However, the Major Depression group had more
comorbid conditions including anxiety disorders,
suicidal behaviors and alcohol intoxication, as well
as more severe stressors at the onset of their illness.
Other factors such as peer relationships and patholo-
gical behaviors did not differ between the groups,
although treatment seeking was greater in the
Major Depression group (35%) than it was in the
Dysthymic group (24%).
Others have suggested that although Dysthymia is a
chronic, low grade form of depression, its morbidity
rate is as high as that of Major Depression, and
Dysthymia would be expected to increase the risk for
Major Depressive Disorder [Griffiths et al., 2000].
These authors suggested that Dysthymia may stem
from disturbances of neuroendocrine and neurotrans-
mitter functioning (e.g. Corticotropin Releasing Hor-
mone, the precursor of cortisol, or norepinephrine).
They also claimed that the persistence of the syndrome
makes those individuals also vulnerable to major
depression. Neurochemical disturbances associated
with Dysthymia may also serve to increase the
recurrence or relapse rate. In addition, lower ratings
for social functioning have been reported for dysthymia
[Yang and Dunner, 2001].
In other studies, groups with Major Depression and
Dysthymia could not be differentiated on socio-
demographic, clinical, family or life events variables
[Goodman et al., 2000; McCullough et al., 2000].
Thus, this literature is limited and inconclusive.
Further, no literature could be found on the differ-
ential effects of these different types of depression on
pregnancy.
This study is the first to explore the differential
effects of Major Depression and Dysthymia on
pregnant women’s psychological stress, on their corti-
sol and norepinephrine levels, and on the measure-
ments of their fetuses in the same study. Prenatal
cortisol and norepinephrine were assayed inasmuch as
Griffiths et al. [2000] had suggested that cortisol and
norepinephrine may be elevated in these conditions.
Also, cortisol has been implicated as a contributor to
prematurity [Field et al., 2004] and norepinephrine has
been correlated with uterine artery resistance and fetal
growth deprivation via decreased blood flow to the
fetus [Glover et al., 1999].
METHOD
PARTICIPANTS
The participants were 102 depressed pregnant
women (N5 48 with Dysthymia, N5 54 with Major
Depression). The mothers averaged 27.2 years of age,
their socioeconomic status was low to middle (M5 4.0
on the Hollingshead Index), and they were distributed
54% Hispanic, 26% African American and 20% non-
Hispanic White.
PROCEDURE
Two hundred-eighty pregnant women were recruited
at prenatal clinics at their first ultrasound visit (M5 18
weeks gestation, R5 16–22 weeks). Following in-
formed consent, the 280 pregnant women were
administered the Structured Clinical Interview for
Depression (SCID) by research associates supervised
by a clinical psychologist. Although illicit drug use was
an exclusionary criterion, none of the women reported
this problem. Of the sample recruited, 102 of the
women were diagnosed with Dysthymia (N5 48) or
Major Depression (N5 52) based on the SCID. The
two groups of women did not differ on their gestational
age at the time of their ultrasounds. Women who met
the criteria for both MDD and Dysthymia were
excluded (N5 14) given their relatively smaller sample
size. Similarly, co-morbid depression and anxiety
women were excluded because they were unevenly
distributed across the MDD and Dysthymia groups.
The depressed pregnant women were then given self-
report measures including the Center for Epidemiolo-
gical Studies-Depression (CES-D) scale for depressive
symptoms, the State/Trait Anxiety Inventory (STAI),
the State/Trait Anger Inventory (STAXI), the Daily
Hassles scale, and the Behavioral Inhibition and
Activation scales (BIS/BAS). The ultrasonographer
recorded fetal measurements including biparietal dia-
meter, femur length, head circumference, and abdom-
inal circumference, and from those measures, fetal
weight was calculated. Finally, the mothers provided a
morning urine sample to be assayed for prenatal
cortisol and norepinephrine levels.
STRUCTURED CLINICAL INTERVIEW
FOR DSM-IV AXIS I DISORDERS (SCID-D)
All women in the study were given the SCID-I (non-
patient edition: research version) interview to deter-
mine depression and anxiety diagnoses and to screen
out other disorders including bipolar disorder, schizo-
phrenia and other psychotic disorders. The women
were diagnosed with Dysthymia or Major Depression
on the SCID based on DSM IV symptoms. The SCID
was administered by research associates following
training and with continuing supervision by a clinical
psychologist. These depressed women were also
referred to our collaborating psychiatrist at the medical
school psychiatric treatment center.
Center for Epidemiological Studies Depression
Scale. This 20-item scale was included to assess
symptoms of depression [Radloff, 1977]. The subject is
asked to report on her feelings during the preceding
week. The scale has adequate test/retest reliability
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(.60 over several weeks), internal consistency (.80–.90)
and concurrent validity [Wells et al., 1987]. Scores can
range from 0 to 60. A score of 16 on the CES-D is
considered the cut-point for depression [Radloff,
1991].
SELF-REPORT MEASURES
State/Trait Anxiety Inventory. This scale was
used to assess anxiety levels in the different depression
groups [Spielberger et al., 1970]. The State/Trait
Anxiety Inventory is composed of 20 items and is
summarized by a score ranging from 20 to 90 and
assesses how the subject usually feels in terms of
severity (‘‘not at all’’ to ‘‘very much so’’). Characteristic
items include ‘‘I feel nervous’’ and ‘‘I feel calm.’’
Research has demonstrated that the STAI has adequate
concurrent validity and internal consistency (r5 .83).
The cutoff score for high anxiety is 48.
State/Trait Anger Inventory. This is a 10-item
inventory that assesses general feelings of anger based
on a four-point Likert scale ranging from 1 (almost
never) to 4 (almost always) [Spielberger et al., 1983].
Typical questions include ‘‘I am quick tempered’’ and ‘‘I
fly off the handle’’. Scores can range from 10 to 40.
Psychometric properties have been established for the
STAXI on diverse ethnic groups. Reliability coeffi-
cients have been reported between 0.97 (state) and 0.89
(trait).
Daily Hassles Scale. This scale was developed to
assess the degree of hassle being experienced by
expectant mothers [Field, 2003]. The 16 items on a
four-point Likert scale include questions on people
such as family members, landlord and friends creating
hassles and the act of finding resources as creating
hassles. Scores can range from 16 to 64.
The Behavioral Inhibition/Behavioral Approach
System Questionnaire. The BIS/BAS is a 24-item
questionnaire consisting of personal statements fol-
lowed by four severity options ranging from very true
to very false [Carver and White, 1994]. Scores can
range from 24 to 96. The BIS/BAS is designed to assess
the tendency to behave in response to reward or in
response to punishment. High BIS scores reflect
withdrawal behavior, and high BAS scores reflect
intrusive behavior.
Urine assay. Urines were collected in specimen
containers by the women during their morning
ultrasound clinic visits. Although several saliva samples
may have been more representative of 24 hr Hypotha-
lamic Pituitary Adrenal axis function, the urines were a
convenience sample because the mothers’ time at the
clinic was limited, and urine samples were routine for
clinic. They were then frozen, and sent to Saul
Schanberg, M.D., Ph.D. at Duke University Medical
School, where they were assayed for cortisol and
norepinephrine. Cortisol was measured in urine by
radioimmunoassay using a specific antiserum from
Radioassay Systems Laboratories. The sensitivity of the
assay is 0.025 ng/tube. The inter-assay and intra-assay
coefficient of variation is less than 10% and 5%,
respectively. Analysis of urinary norepinephrine was
conducted by high-pressure liquid chromatography
(HPLC) and electrochemical detection.
Ultrasound assessments. These assessments were
conducted at 16–22 weeks gestation at the university
ultrasound clinic and were the only scheduled ultra-
sound appointments for these women. All ultrasound
measurements were performed by clinical ultrasono-
graphers using a color ultrasound machine with 3.5 and
5-Mhz curvilinear abdominal probes. All ultrasono-
graphers were blind to the diagnoses of the pregnant
women.
Fetal measurements. Fetal measurements includ-
ing femur length (FL), abdominal circumference (AC),
head circumference (HC) and biparietal diameter
(BPD) were made in centimeters using standard clinical
measurement protocols [Chitty et al., 1994]. The
Shepard et al. [1982], fetal weight estimation algo-
rithms were used to estimate fetal weight from fetal
ultrasound measurements.
RESULTS
Multivariate analyses of variance (MANOVAs) were
conducted on the self-report measures, the biochemical
measures, and fetal growth measures. Following sig-
nificant MANOVAs, univariate ANOVAs were con-
ducted with the group assignment (Dysthymia/Major
Depression) being the between groups measure. On the
demographic variables, the groups differed on socio-
economic status (M5 4.2 for the Dysthymic group and
M5 3.8 for the Major Depression group, F5 4.09,
Po.05). Inasmuch as the groups differed on this
background measure, socioeconomic status was en-
tered as a covariate in the analyses.
SELF-REPORT MEASURES
As can be seen in Table 1, the Major Depression
group received more severe scores on all of the self-
report measures. Their higher scores suggested: (1)
more depressive symptoms on the CES-D; (2) higher
anxiety levels on the STAI; (3) higher anger levels on
the STAXI; (4) more hassles on the Daily Hassles scale;
and (5) greater inhibition on the BIS/BAS scales.
BIOCHEMICAL MEASUREMENTS
As can be seen in Table 2, the Dysthymic group had
higher prenatal cortisol levels, although their norepi-
nephrine levels did not differ from those of the Major
Depression group.
FETAL GROWTH MEASURES
As can be seen in Table 2, the Dysthymic group had
lower fetal measurements including femur length,
abdominal circumference, and fetal weight.
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DISCUSSION
The more severe scores on the self-report measures
of the Major Depression group suggested greater
symptoms for that group. This group scored higher
on the depressive symptoms scale (CES-D) as well as
the somatic/vegetative and positive affect subscales of
the CES-D. They also received higher scores on the
anxiety (STAI), anger (STAXI), inhibition (BIS/BAS)
and Daily Hassles measures. The greater symptoms for
the Major Depression group in this study are consistent
with those noted by Klonsky and Bartelson [2000], who
reported that their Major Depression group had more
severe physical/somatic symptoms. This self-report
profile is also consistent with more comorbid condi-
tions associated with Major Depressive Disorder, as
opposed to Dysthymia, including anxiety disorder
[Flament et al., 2001]. The higher inhibition scores
for the Major Depression group may be consistent with
their higher anxiety scores. Although daily hassles are
often associated with lower socioeconomic status, the
Major Depression group was reporting more daily
hassles, even though their socioeconomic status was
higher than that of the Dysthymic group. The
reporting of more symptoms on all of these scales by
the Major Depression group may relate to the acute
nature of their depressive episodes. The Dysthymic
group may be under-reporting symptoms that they
have grown accustomed to by virtue of their chronic
condition.
The inconsistency between the self-report measures
and the maternal biochemical and fetal measurements
data are somewhat surprising. Although the Major
Depression group was scoring worse on the self-report
measures, the Dysthymic group had significantly
higher prenatal cortisol levels, which may have con-
tributed to the lower fetal weight, lesser femur length
and lesser abdominal circumference noted in the
ultrasound examinations of their fetuses. In previous
studies [Field et al., 2004], elevated cortisol has been
associated with lower birthweight. Typically, prenatal
norepinephrine is also inversely related to fetal
TABLE 2. Maternal biochemical and fetal growth data (standard deviations in parentheses)
Groups
Measures Dysthymic Major depression F P
Biochemical
Prenatal cortisol 382.8 (256.6) 213.4 (124.6) 3.86 .05
Prenatal norepinephrine 63.8 (15.0) 63.0 (16.8) NS
Fetal growth
Fetal weighta 446.3 (348.5) 485.9 (344.6) 3.42 .05
Biparietal diameterb 4.9 (2.2) 6.8 (4.9) NS
Femur lengthb 3.5 (2.2) 4.8 (3.1) 3.37 .05
Head circumferenceb 15.7 (6.1) 24.0 (19.5) NS
Abdominal circumferenceb 14.0 (5.9) 23.4 (14.6) 3.38 .05
aGrams.
bCentimeters.
TABLE 1. Pregnancy self-report measures (standard deviations in parentheses)
Groups
Measures Dysthymic Major depression F P
Depression (CES-D) 23.4 (9.5) 30.7 (9.1) 15.27 .000
Depressed affect 6.6 (3.3) 7.3 (4.4) NS
Somatic/vegetative 6.9 (3.3) 9.9 (2.7) 9.85 .003
Positive affect 5.0 (3.2) 6.8 (1.7) 4.06 .05
Interpersonal distress 1.2 (1.3) 1.8 (1.0) NS
Anxiety (STAI) 45.2 (10.4) 49.8 (10.4) 4.84 .03
Anger (STAXI) 18.4 (4.5) 22.2 (6.2) 9.48 .003
Daily hassles 24.7 (7.5) 28.2 (7.7) 3.62 .05
Behavioral inhibition 16.1 (2.7) 19.3 (3.6) 10.29 .002
Behavioral activation 38.1 (8.4) 41.3 (7.2) NS
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measurements [Glover et al., 1999]. However, in this
study, the groups were comparable on prenatal
norepinephrine. The elevated cortisol and lower
fetal measurements appear to be a consistent profile,
and one that has been described by others as disturbed
neuroendocrine and neurotransmitter functioning
[Griffiths et al., 2000]. We have noted significantly
higher cortisol levels and lower fetal growth measures
in depressed women versus non-depressed women
and their fetuses [Diego et al., 2006], and the cortisol
levels are higher and fetal growth measures lower
in these Dysthymia and MDD groups than in the
Diego et al. [2006] study. These neurochemical
imbalances may contribute to a Dysthymic state
which may, in turn, affect fetal measurements. The
chronicity of this state may contribute to the Dysthy-
mic women underreporting their symptoms or even
experiencing fewer symptoms than are typical of
Dysthymia.
Thus, a dichotomous picture emerged, with the
Major Depression group appearing to have more
severe symptoms based on self-report measures, and
the Dysthymic group appearing to have more imbal-
anced prenatal biochemistry and smaller fetal measure-
ments. None of these differences are likely to be
treatment effects (which generally favor the Major
Depression group), because none of these women
were receiving treatment during pregnancy. Further
research is needed on other self-report measures
and biochemical and physiological variables and
across pregnancy to determine the validity of these
different profiles. The lack of prenatal treatment
(both psychotherapy and antidepressant medications)
in these groups, whereas not surprising given earlier
studies documenting the under-treatment of prenatal
depression, highlights the need for this at-risk
population to be recognized and referred for treatment
more readily.
Both the Major Depression and Dysthymic groups
would, then, appear to have prenatal problems. The
Major Depression group, based on the self-reported
symptoms (depression, anxiety, anger, inhibition and
daily hassles), appear to be aware of their distress.
Although this is not reflected in their prenatal cortisol
levels, their felt distress may be affecting other
chemistry that was not measured here. In contrast,
the Dysthymic group had a less severe pattern of self-
report problems, although they seemed to be dis-
tressed, as manifested by their significantly higher
cortisol levels, and by the effects cortisol may have had
on their inferior fetal measurements including fetal
weight, femur length and abdominal circumference.
The other measurements (biparietal diameter and head
circumference), although not significantly lower,
tended to be lower in the Dysthymic group fetuses.
Although the literature suggests that Major Depression
Disorder may be the more severe diagnosis [Klonsky
and Bartelson, 2000], these data highlight a potential
biochemical imbalance and lower fetal measurements
for the Dysthymic group, suggesting that both types of
measures on both groups are in need of further study.
In any future study, the limitations of this study need
to be corrected. The inclusion of a control group
makes it easier to interpret the extent of risk for these
depressed groups. Comparisons between women who
had recurrent MDD versus single episode MDD would
also be important. Checking reliability of the SCID
examiners and the ultrasonographers would also be
important. Nonetheless, these preliminary findings
highlight the need for further studying pregnant
women with MDD and Dysthymia.
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